ClinicalTrials.gg
Active, not recruitingNCT04631692DECODEUpdated Apr 2, 2025

Evaluating a Health Literacy Intervention to Improve Colorectal Cancer Screening in Underserved Areas

An interventional study of Health literacy intervention in Colorectal Cancer Screening, sponsored by University Paul Sabatier of Toulouse. Active, not recruiting at 4 sites in France. Open to participants aged 50 Years to 74 Years. Per ClinicalTrials.gov, last updated 2025-04-02.

Sponsored by University Paul Sabatier of Toulouse · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,025
Allocation
Randomized
Ages
50 Years to 74 Years
Sex
All
01

Study summary

The aim of this project is to assess the impact of a health literacy (HL) intervention combining HL and CRC screening training for general practitioners with a short brochure and video targeting eligible patients to increase CRC screening and other secondary outcomes in four underserved geographic areas in France. The investigators will use a two-arm randomized controlled cluster trial at 8 clusters (2 per area) primarily serving underserved populations across 4 geographic areas in France with 32 primary care physicians and 1024 patients recruited.

Read the detailed description

Background Colorectal cancer (CRC) is a leading cause of cancer burden worldwide and the third most commonly diagnosed cancer in France (with 44,000 new cases in France each year). Systematic uptake of CRC screening can improve survival rates. However, people with limited health literacy (HL) and lower socioeconomic position rarely participate. The overall goal is to assess the impact of a HL intervention combining HL and CRC screening training for general practitioners with a short brochure and video targeting eligible patients to increase CRC screening and other secondary outcomes in four underserved geographic areas in France.

Methods The investigators will use a two-arm randomized controlled cluster trial at 8 clusters (2 per area) primarily serving underserved populations across 4 geographic areas in France with 32 primary care physicians and 1024 patients recruited. Primary care physicians practicing in underserved areas (identified using the European Deprivation Index and French Deprivation index) will be block-randomized to: 1) a combined intervention (HL and colorectal cancer training + brochure and video for eligible patients) or 2) usual care. The investigators will include all people between 50 and 74 years old who are eligible for CRC screening. The project will follow a community-based participatory research approach. The primary outcome is CRC screening uptake. The project will also include a qualitative needs assessment (focus groups and interviews) prior to finalizing the intervention and to test the acceptability of the combined intervention before the trial. After completing recruitment, semi-structured interviews will be conducted with up to 8 health professionals in each region (up to 24) and 6 to 12 patients per region (up to 48) based on data saturation. The investigators will explore strategies that promote the intervention's sustained use and rapid implementation using the Normalization Process Theory. A regression framework and mediation analyses will be used.

Discussion Limited HL and its impact on the general population is a growing public health and policy challenge worldwide. It has received limited attention in France. A combined HL intervention could reduce disparities in CRC screening, increase screening rates among most vulnerable populations, and increase knowledge and activation (beneficial in the context of repeat screening).

02

Conditions studied

  • Colorectal Cancer Screening
03

In context

Colorectal Neoplasms

6,541 studies on the registry are indexed under Colorectal Neoplasms; 1,667 are open to participants now.

This study's enrollment of 1,025 is above the median of 76 across 4,800 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

University Paul Sabatier of Toulouse is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People between 50 and 74 years old who are eligible for colorectal cancer screening and seen by a participating general practitioner.
  • People who are able to complete a questionnaire in French, either alone or with help from a caregiver or relative.
  • People with intellectual disability will be included as long as they are able to complete a questionnaire alone or with help from a caregiver or relative.

Exclusion criteria

Exclusion Criteria:

- People whose mental health status does preclude participation in the study, as determined by the participating primary care practitioner or their qualified staff.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
1,025 participants (actual)

Study arms

  • No intervention
    Usual care

    Usual care in participating primary care practices.

  • Active comparator
    Health literacy intervention

    Health literacy intervention combining health literacy and colorectal cancer screening training for general practitioners with a short brochure and video targeting eligible patients.

    Behavioral: Health literacy intervention

Interventions

  • BehavioralHealth literacy intervention

    We will translate and adapt an intervention developed by Ferreira et al. to address health literacy and improve CRC screening. This intervention combined a 2-hour health literacy training targeting primary care physicians (which also included information about CRC screening) and a patient level intervention that consisted of a brochure and video. In order to promote generalizability, large-scale diffusion, dissemination and sustained use beyond the funded-research period, we will use blended learning to develop a 2-hour e-learning health literacy training in French and a one-hour booster session. The patient-facing intervention (video + brochure) will follow key plain language and health literacy principles to translate evidence-based information in content that all patients can understand. Existing materials developed in France will be used and adapted as relevant.

06

What researchers measure

Primary outcomes

  1. Colorectal cancer screening uptake

    This information will be collected by each regional screening coordination center of the four participating regions, in collaboration with the health insurance (CPAM) at 6 months (for feedback to general practitioners in the intervention arm) and 1-year post enrollment into the study. It will also be collected using self-report in the patient questionnaire 1-year post enrollment.

    Time frame: up to 1-year post enrollment

07

Study locations

4 sites
  • Service de recherche et épidémiologie cliniques
    Lyon, France
  • Espace santé APHM
    Marseille, France
  • Assistance Publique Hopitaux de Paris
    Paris, France
  • Faculté de médecine
    Toulouse, France
08

References and documents

Publications

  • Durand MA, Lamouroux A, Redmond NM, Rotily M, Bourmaud A, Schott AM, Auger-Aubin I, Frachon A, Exbrayat C, Balamou C, Gimenez L, Grosclaude P, Moumjid N, Haesebaert J, Massy HD, Bardes J, Touzani R, Diant LBEF, Casanova C, Seitz JF, Mancini J, Delpierre C. Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial. BMC Public Health. 2021 Sep 16;21(1):1684. doi: 10.1186/s12889-021-11565-3. PubMed 34530800 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04631692
Lead sponsor
University Paul Sabatier of Toulouse
Collaborators
National Cancer Institute, France, Institut National de la Santé Et de la Recherche Médicale, France, Aix Marseille Université, Assistance Publique Hopitaux De Marseille, Laboratoire HESPER-EA 7425, INSERM, UMR-S 1123 ECEVE Université de Paris, University Paris 7 - Denis Diderot, Institut Paoli-Calmettes
Responsible party
Marie-Anne Durand (Researcher, University Paul Sabatier of Toulouse) — Principal investigator
First posted
Nov 17, 2020
Start date
Oct 1, 2021
Primary completion
Dec 7, 2024
Completion
Apr 14, 2025 (estimated)
Last update
Apr 2, 2025

Study contacts

Marie-Anne Durand
principal investigator · Université Toulouse III Paul Sabatier
Niamh M REDMOND, PhD
principal investigator · Université Toulouse III Paul Sabatier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion